ISO Certified Companies Manufacturers High Quality Noopept High concentration

Noopept was invented in 1996. Its structure is based on that of cycloalanineglycine; an endogenous neuropeptide.

Cycloglycine is known to promote the expression of brain-derived neurotrophic factor. So the researchers hypothesized that a cycloalanine-glycine-based nootropic would have similar effects, and that's what Noopept is.

This product is a drug intermediate, mainly used to treat and prevent osteoporosis, cardiovascular, diabetes, arteriosclerosis and other diseases.

For biochemical research. Used as pharmaceutical intermediates or raw materials for the synthesis of nateglinide and other drugs.

Noopept has nootropic, neuroprotective and antioxidant properties. It improves learning, memory, all stages of processing: integration of information and initial processing of information retrieval. Noopept helps restore memory and other cognitive functions.